Hydrodynamic limit of asymmetric exclusion processes under diffusive scaling in d≥3d\ge 3

We consider the asymmetric exclusion process. We start from a profile which is constant along the drift direction and prove that the density profile, under a diffusive rescaling of time, converges to the solution of a parabolic equation

Investigation on The Mechanical Characteristics Of Sawdust And Chipwood Filled Epoxy

In furniture and paper industries, huge amount of wood flakes and wood flours in the form of chip wood and sawdust are always found as waste. This is known as natural fiber, a renewable source that available at low cost. This study was carried out for three different sizes of fiber which categories into “soft”, “rough” and “coarse” particles that derived from chip wood (CW) and sawdust (SW). The SW and CW fiber were blended with epoxy by using hand tools machine respectively, which then open molding was employed to form a fiber composite and specimens’ accordance to the ASTM standards. It was found that the strength of tensile value for the rough size particles of SW were higher than the CW. The works presented agood quality of SW and CW fiber composite had been produced which can be used for home furniture utilities

Effect of maize, rumen-protected fat and whey permeate on energy utilisation and milk fat composition in lactating goats

The efficiency of utilisation of diets with different proportions of energy sources (starch, fat, lactose) was studied with three pairs of lactating Saanen goats; the animals were fed, in a Latin square design, 3 silage-based diets containing (on DM basis) the following energy sources: 32% maize meal (diet M); 4.7% rumen-protected fat (Megalac®) and 23.5% maize meal (diet F); 9.8% milk whey permeate powder and 22.3% maize meal (diet W). During each of the three experimental periods, 8 days of total collection balance trials were conducted during which goats were allocated for 72 h (three 24 h cycles) in open circuit respiration chambers to determine methane and heat production and, hence, the energy balance. Diet F, in comparison with diets M and W, significantly increased the milk fat content (4.13 vs 3.11 and 3.14%, P<0.001) and the 4%-FCM yield (3367 vs 2927 and 3055 g/d, P<0.01 and P<0.05, respectively), while no relevant changes were observed for milk protein content and yield. Energy digestibility was equal in diets F and W. Megalac® did not decrease fibre digestibility. The partition of the gross energy intake (EI) differed significantly between diets: diet M had lower DE (72.4 vs 74.3 and 74.3%; P<0.01) and ME (62.1 vs 64.7 and 63.5%; P<0.05) in comparison with diets F and W, respectively. Energy lost as methane was not significantly decreased by the inclusion of rumen- protected fat in the diet, although a trend for a reduction of methanogenesis was observed. Heat production deter- mined by treatment F was lower in comparison with the other treatments. This difference was almost significant (P=0.056) when expressed as a percentage of the ME. Milk energy output increased significantly (+12%, P<0.001) by including fat in the diet, as compared with treatments M and W: 21.4 vs 19.1 and 19.0% of the EI. The net ener- gy content of the protected fat was 27.94 MJ NEl/kg DM (+340% vs maize meal); its kl value resulted 0.77. The corresponding values for whey permeate were 7.76 MJ NEl/kg DM (-5% vs maize meal) and 0.50, respectively. Summarizing, the efficiency of energy utilization in diet M was significantly lower in comparison with the other two diets in terms of digestibility and metabolisability, while its NEl content was similar to that of diet W. On the other hand, diet F had a significantly higher ME (P<0.01) and NEl (P<0.05) as compared to the other two diets. Diet F greatly influenced the fatty acid composition of the milk fat with less short (-30%) and medium (-33%) chain fatty acids and more (+18%) long chain fatty acids. In conclusion, whey permeate and even more Megalac® can be suc- cessfully used as feed ingredients in the diet of highly productive lactating goats, but the economical convenience of their utilisation must be evaluated based on the market values of feedstuffs

Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older

HIV/AIDS prevention and care efforts are directed to individuals of reproductive age (15&#x2013;49 yrs). With the extension of sexual life of older people, they became a growing population at risk of HIV infection, usually not included in prevention strategies. In order to evaluate clinical profile of HIV/AIDS pts diagnosed at 50 yrs or older assisted in an HIV outpatient center in Buenos Aires, we retrospectively assessed clinical records of pts initiating care between Jan 1986 and Dec 2011. Age, CD4 cells and viral load (pVL) at HIV diagnosis and most recent value, opportunistic infections (OIs), co-morbidities and antiretroviral therapy (ARV) were recorded. Of 10,998 pts assisted in the 26-yr period, 495 (4.5%) were&#x2265;50 yrs old at HIV diagnosis; median annual diagnoses: 18.5 (IQR 3.3&#x2013;30.3) without significant changes in the last 20 yrs. Demographics: median age 54.7 yrs (IQR 51.8&#x2013;59.2, rank 50&#x2013;80), 76.6% male. Risk behavior: HTX 61.4%, MSM 34.1%, others 4.4%. 55.4% of HIV diagnoses occurred during hospitalization or simultaneously with acute OIs. One third (n=176) had AIDS at diagnosis, 24% had history of STDs. HCV co-infection 5.7%, past HBV infection 28.1% and chronic HBV infection 5.1%. Median CD4 cells at HIV diagnosis: 223.5 (13.7%) (IQR 98.8&#x2013;420.3), initial pVL 60,000 cp/mL (IQR 9,995.5&#x2013;208,391). 69.3% of pts started ARV therapy during follow-up (FU), and the median time between diagnosis and treatment initiation was 3.4 mo (IQR 0.7&#x2013;14); 56.9% of them started a non-nucleoside-based regimen (ZDV/3TC/EFV), 28.3% a PI-based regimen (ZDV/3TC/IDV) and 14.6% a nucleoside-based regimen (ZDV/ddI pre-HAART era). After a year (&#x00B1;6 mo), 63.8% pts achieved undetectable pVL and gained 136 CD4 cells from BSL (IQR 83&#x2013;204). After 40.6 mo of FU (IQR 6.7-89.8), 66.3% are alive, 7.1% died (68.6% of HIV-related diseases) and 26.7% are lost to FU. Co-morbidities were present in 125 (25.3%), mainly hypertension, increased lipids, CVD and DBT. Among treated pts, 70.6% achieved pVL&#x3C;50 cp/mL, with a median increase of CD4 cells up to 410 (22%) (IQR 281.5&#x2013;563.9) from BSL. 51% (176) changed ARV therapy due to toxicity/AE: 54.5%, ARV failure: 29.5% and simplification: 14.8%. Stable HIV epidemic in older people reinforce the need of specific prevention approaches, while growing age of HIV individuals in care highlights to consider risks associated to older age. Late presentation to care needs to be specifically addressed. Response to treatment is remarkable high in this population

Prevalent Leadership Profile: A Research on Management of Innovation in the Military Organization

In this work we investigate prevailing leadership in a military organization. Our study has a multi-disciplinarily nature as it focuses on Organizational Innovation and the profile of a leader as well as a little investigation on history of the development of a military organization Our main objective is to identify the profile of a strategic prevalent leadership at the Firemen Corporation in Porto Velho, Rondonia – Northern Brazil. We propose to describe the process of nomination for someone to exercise the role of a leader used in the military structure. In this context, we make a survey of the prevalent elements considering the profile of leadership in the face of organizational innovation having in mind the expectation of the people involved in the process of research. At the end we conduct a critical analysis comparing the prevalent elements identified in our study with the expectation of innovation revealed by the military structure investigated. We apply the method of content analysis through convenient procedures. As a result, we present the elements which show prevalence for the definition of the leadership profile of the investigated military structure. We hope our research can contribute to the studies in the field of leadership, as we still have few references in the area of knowledge

Parametric Study on Parameter Effects in Hybrid Micro Wire Electrical Discharge Turning

In this paper, a comprehensive parametric study on the effects of operating parameters in wire electrical discharge turning (WEDT) process was conducted. Total of eleven operating parameters were considered against the machined surface quality. The research focuses on the micro-turning of Ti6Al4V materials using Taguchi’s L12 orthogonal array at two level experimental designs. Analysis of variance (ANOVA) and signal-to-noise (S/N) ratio were used as statistical tools to evaluate the significances of the parameters. It was found that among the eleven operating parameters, only four parameters dominated and have statistical significant effects on the surface roughness values as discovered by ANOVA. The operating parameters were the rotational spindle speed (28.34%) as the most dominating factor, followed by intensity of pulse (24.18%), wire tension (20.57%) and stabilizer E (11.97%)

Fluidized Bed Granulation Parameters Effect on Urea Granule Physical Properties

The aim of this study is to determine the effect of different airflow patterns and process conditions on the physical properties of granules produced using fluidized bed granulation technique. It was observed that spiral airflow was the most important factor to produce granules with required size and density under similar process conditions if compared with normal airflow. From ANOVA, binder spray pressure and bag shake duration showed the strongest influence on hardness of granules on both types of airflow patterns. Optimization studies for spiral and normal airflow proved that granules with desired density and hardness can be produced at middle level of wind velocity and binder spray pressure together with high level bag shake duration. For spiral airflow, the optimum value for wind velocity, binder spray pressure and bag shake duration was 28 m/s, 0.31 MPa and 60 s respectively; for normal airflow, it was 25 m/s, 0.20 MPa and 15 s respectively

Early skewed differentiation and PD-1 expression in CD4+ cells relate to immune dysfunction and viral persistence in individuals living with HIV 1 year post-cART initiation

Achieving HIV functional cure is a priority. Strategies such as adoptive cell transfer have been assayed, without success yet mainly due to immune dysfunctions observed among individuals. Samples from 25 HIV+ subjects were collected at diagnosis (baseline sample, BSL) and one year post-cART initiation (post- cART ). At BSL, bulk and HIV-specific CD4 phenotype (CD45RO , CCR 7, CD95 and PD1 expression) was assessed by flow cytometry after a short stimulation with HIV peptides. Also, proportion of CD4+/HLA-DR+/ CD38+ cells was measured. At post-cART , HIV-specific CD8TC s were obtained after 2-week expansion with peptides. Phenotype and antiviral activity (VIA and VITA L assays) were evaluated post-expansion. Plasma CXCL10 (IP-10) was assessed by ELISA. Cell-associated HIV DNA (total and integrated) and unspliced (US) and multiply-spliced (MS) RNA were quantified by real-time PCR. Non-parametric statistics were applied. Early CD4TC exhaustion, elevated activation and inadequate differentiation seem to be associated with viral persistence, inflammation, as well as with the phenotype and antiviral capacity of HIV-specific CD8TC s that persist one year after cART is initiated. These parameters could serve as predictors of CD8TC function on treated subjects.Fil: Salido, Jimena Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Czernikier, Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Trifone, César Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Figueroa, M. I.. Fundación Huésped; ArgentinaFil: Salomon, Horacio Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Cahn, P.. Fundación Huésped; ArgentinaFil: Sued, O.. Fundación Huésped; ArgentinaFil: Laufer, Natalia Lorna. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Ghiglione, Yanina Alexandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Turk, Gabriela Julia Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentin

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)

OBJECTIVES: To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with acute/recent HIV-1 infection in Barcelona during the period 1997-2012. METHODS: Patients from the "Hospital Clinic Primary HIV-1 Infection Cohort" with a genotyping test performed within 180 days of infection were included. The 2009 WHO List of Mutations for Surveillance of Transmitted HIV-1 Drug Resistance was used for estimating the prevalence of TDR and phylogenetic analysis for subtype determination. RESULTS: 189 patients with acute/recent HIV-1 infection were analyzed in 4 time periods (1997-2000, n=28; 2001-4, n=42; 2005-8, n=55 and 2009-12, n=64). The proportion of patients with acute/recent HIV-1 infection with respect to the total of newly HIV-diagnosed patients in our center increased over the time and was 2.18%, 3.82%, 4.15% and 4.55% for the 4 periods, respectively (p=0.005). The global prevalence of TDR was 9%, or 17.9%, 9.5%, 3.6% and 9.4% by study period (p=0.2). The increase in the last period was driven by protease-inhibitor and nucleoside-reverse-transcriptase-inhibitor resistance mutations while non-nucleoside-reverse-transcriptase inhibitor TDR and TDR of more than one family decreased. The overall prevalence of non-B subtypes was 11.1%, or 0%, 4.8%, 9.1% and 20.3 by study period (p=0.01). B/F recombinants, B/G recombinants and subtype F emerged in the last period. We also noticed an increase in the number of immigrant patients (p=0.052). The proportion of men-who-have-sex-with-men (MSM) among patients with acute/recent HIV-1 infection increased over the time (p=0.04). CONCLUSIONS: The overall prevalence of TDR in patients with acute/recent HIV-1 infection in Barcelona was 9%, and it has stayed relatively stable in recent years. Non-B subtypes and immigrants proportions progressively increased